Logo image of XHR

XENIA HOTELS & RESORTS INC (XHR) Stock Fundamental Analysis

USA - NYSE:XHR - US9840171030 - REIT

14.66 USD
-0.17 (-1.15%)
Last: 9/19/2025, 11:36:25 AM
Fundamental Rating

5

Taking everything into account, XHR scores 5 out of 10 in our fundamental rating. XHR was compared to 130 industry peers in the Diversified REITs industry. XHR has only an average score on both its financial health and profitability. XHR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

XHR had positive earnings in the past year.
XHR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: XHR reported negative net income in multiple years.
Of the past 5 years XHR 4 years had a positive operating cash flow.
XHR Yearly Net Income VS EBIT VS OCF VS FCFXHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

XHR has a better Return On Assets (2.17%) than 67.69% of its industry peers.
XHR's Return On Equity of 5.14% is fine compared to the rest of the industry. XHR outperforms 66.15% of its industry peers.
XHR has a Return On Invested Capital (2.99%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for XHR is in line with the industry average of 3.05%.
The 3 year average ROIC (2.74%) for XHR is below the current ROIC(2.99%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.17%
ROE 5.14%
ROIC 2.99%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
XHR Yearly ROA, ROE, ROICXHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

XHR has a Profit Margin (5.81%) which is comparable to the rest of the industry.
XHR's Profit Margin has declined in the last couple of years.
XHR's Operating Margin of 9.66% is on the low side compared to the rest of the industry. XHR is outperformed by 78.46% of its industry peers.
XHR's Operating Margin has declined in the last couple of years.
XHR's Gross Margin of 54.73% is on the low side compared to the rest of the industry. XHR is outperformed by 73.85% of its industry peers.
XHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.66%
PM (TTM) 5.81%
GM 54.73%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
XHR Yearly Profit, Operating, Gross MarginsXHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

5

2. Health

2.1 Basic Checks

XHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
XHR has less shares outstanding than it did 1 year ago.
XHR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for XHR has been reduced compared to a year ago.
XHR Yearly Shares OutstandingXHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
XHR Yearly Total Debt VS Total AssetsXHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

XHR has an Altman-Z score of 0.73. This is a bad value and indicates that XHR is not financially healthy and even has some risk of bankruptcy.
XHR has a better Altman-Z score (0.73) than 64.62% of its industry peers.
The Debt to FCF ratio of XHR is 56.29, which is on the high side as it means it would take XHR, 56.29 years of fcf income to pay off all of its debts.
XHR's Debt to FCF ratio of 56.29 is fine compared to the rest of the industry. XHR outperforms 60.77% of its industry peers.
A Debt/Equity ratio of 1.17 is on the high side and indicates that XHR has dependencies on debt financing.
XHR has a Debt to Equity ratio (1.17) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 56.29
Altman-Z 0.73
ROIC/WACC0.4
WACC7.4%
XHR Yearly LT Debt VS Equity VS FCFXHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.64 indicates that XHR should not have too much problems paying its short term obligations.
XHR has a better Current ratio (1.64) than 71.54% of its industry peers.
A Quick Ratio of 1.64 indicates that XHR should not have too much problems paying its short term obligations.
XHR's Quick ratio of 1.64 is fine compared to the rest of the industry. XHR outperforms 71.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
XHR Yearly Current Assets VS Current LiabilitesXHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

XHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 186.36%, which is quite impressive.
XHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.70% yearly.
The Revenue has been growing slightly by 4.81% in the past year.
The Revenue has been decreasing by -1.99% on average over the past years.
EPS 1Y (TTM)186.36%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%273.33%
Revenue 1Y (TTM)4.81%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%5.38%

3.2 Future

The Earnings Per Share is expected to grow by 42.53% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.17% on average over the next years.
EPS Next Y169.33%
EPS Next 2Y16.05%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue Next Year3.62%
Revenue Next 2Y3.23%
Revenue Next 3Y3.17%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XHR Yearly Revenue VS EstimatesXHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
XHR Yearly EPS VS EstimatesXHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.27, XHR is valued on the expensive side.
Based on the Price/Earnings ratio, XHR is valued cheaper than 81.54% of the companies in the same industry.
XHR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 72.57, the valuation of XHR can be described as expensive.
XHR's Price/Forward Earnings ratio is in line with the industry average.
XHR is valuated expensively when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.27
Fwd PE 72.57
XHR Price Earnings VS Forward Price EarningsXHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XHR is valued a bit cheaper than 76.92% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as XHR.
Industry RankSector Rank
P/FCF 55.52
EV/EBITDA 11.38
XHR Per share dataXHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

XHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XHR's earnings are expected to grow with 42.53% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y16.05%
EPS Next 3Y42.53%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.68%, XHR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 6.66, XHR is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.38, XHR pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

The dividend of XHR decreases each year by -15.89%.
XHR has paid a dividend for at least 10 years, which is a reliable track record.
XHR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-15.89%
Div Incr Years2
Div Non Decr Years2
XHR Yearly Dividends per shareXHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

XHR pays out 40.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP40.97%
EPS Next 2Y16.05%
EPS Next 3Y42.53%
XHR Yearly Income VS Free CF VS DividendXHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
XHR Dividend Payout.XHR Dividend Payout, showing the Payout Ratio.XHR Dividend Payout.PayoutRetained Earnings

XENIA HOTELS & RESORTS INC

NYSE:XHR (9/19/2025, 11:36:25 AM)

14.66

-0.17 (-1.15%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners98.26%
Inst Owner Change-1.64%
Ins Owners0.94%
Ins Owner Change0%
Market Cap1.40B
Analysts78
Price Target15.3 (4.37%)
Short Float %4.21%
Short Ratio3.64
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend0.47
Dividend Growth(5Y)-15.89%
DP40.97%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.14)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.72%
Min EPS beat(2)81.79%
Max EPS beat(2)163.65%
EPS beat(4)3
Avg EPS beat(4)13.88%
Min EPS beat(4)-199.01%
Max EPS beat(4)163.65%
EPS beat(8)6
Avg EPS beat(8)71.52%
EPS beat(12)7
Avg EPS beat(12)103.41%
EPS beat(16)10
Avg EPS beat(16)88.82%
Revenue beat(2)2
Avg Revenue beat(2)4.02%
Min Revenue beat(2)3.88%
Max Revenue beat(2)4.16%
Revenue beat(4)2
Avg Revenue beat(4)1.12%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)4.16%
Revenue beat(8)3
Avg Revenue beat(8)0.33%
Revenue beat(12)5
Avg Revenue beat(12)0.23%
Revenue beat(16)9
Avg Revenue beat(16)1.91%
PT rev (1m)5.63%
PT rev (3m)10.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-21.57%
EPS NY rev (3m)-21.57%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)1.02%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 23.27
Fwd PE 72.57
P/S 1.31
P/FCF 55.52
P/OCF 8.12
P/B 1.15
P/tB 1.16
EV/EBITDA 11.38
EPS(TTM)0.63
EY4.3%
EPS(NY)0.2
Fwd EY1.38%
FCF(TTM)0.26
FCFY1.8%
OCF(TTM)1.8
OCFY12.31%
SpS11.23
BVpS12.7
TBVpS12.65
PEG (NY)0.14
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.17%
ROE 5.14%
ROCE 3.78%
ROIC 2.99%
ROICexc 3.19%
ROICexgc 3.24%
OM 9.66%
PM (TTM) 5.81%
GM 54.73%
FCFM 2.35%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.99%
ROICexgc(5y)N/A
ROCE(3y)3.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.42%
ROICexc growth 3YN/A
ROICexc growth 5Y-6.41%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 56.29
Debt/EBITDA 6.06
Cap/Depr 112.83%
Cap/Sales 13.73%
Interest Coverage 1.19
Cash Conversion 73.66%
Profit Quality 40.49%
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z 0.73
F-Score8
WACC7.4%
ROIC/WACC0.4
Cap/Depr(3y)167.19%
Cap/Depr(5y)114.68%
Cap/Sales(3y)21.77%
Cap/Sales(5y)17.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)186.36%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%273.33%
EPS Next Y169.33%
EPS Next 2Y16.05%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue 1Y (TTM)4.81%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%5.38%
Revenue Next Year3.62%
Revenue Next 2Y3.23%
Revenue Next 3Y3.17%
Revenue Next 5YN/A
EBIT growth 1Y20.56%
EBIT growth 3YN/A
EBIT growth 5Y-8.94%
EBIT Next Year195.4%
EBIT Next 3Y48.07%
EBIT Next 5YN/A
FCF growth 1Y-76.27%
FCF growth 3Y37.05%
FCF growth 5YN/A
OCF growth 1Y-8.64%
OCF growth 3Y58.91%
OCF growth 5Y-7.87%